当前位置:首页 - 行情中心 - 上海医药(601607) - 财务分析

上海医药

(601607)

  

流通市值:506.80亿  总市值:673.81亿
流通股本:27.89亿   总股本:37.08亿

上海医药(601607)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润16.40亿元,每股收益0.36元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益8530096.93万元,未分配利润3788027.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产22587189.17万元,负债14057092.24万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入70,762,515,910.94275,250,934,889.66209,628,733,748.35139,413,145,524.43
营业总成本68,666,635,360.52267,676,306,689.98203,433,368,171.18134,890,168,760.01
营业利润2,146,390,114.158,140,712,946.176,668,766,941.124,830,896,881.37
利润总额2,152,717,007.538,020,006,543.746,644,377,262.894,822,020,675.99
净利润1,640,193,471.65,870,011,314.885,023,298,063.883,597,363,036.62
其他综合收益-3,441,851.94-62,617,948.59-26,585,406.09-35,643,937.69
综合收益总额1,636,751,619.665,807,393,366.294,996,712,657.793,561,719,098.93
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计177,311,702,074.79171,823,107,421.97173,787,729,817.04171,602,970,409.07
非流动资产合计48,560,189,615.0249,386,322,726.249,953,615,974.6649,732,901,419.99
资产总计225,871,891,689.81221,209,430,148.17223,741,345,791.7221,335,871,829.06
流动负债合计130,813,134,867.82126,038,386,279.1129,532,122,995.82129,104,115,224.21
非流动负债合计9,757,787,539.4211,428,680,14811,051,710,878.2510,003,135,409.79
负债合计140,570,922,407.24137,467,066,427.1140,583,833,874.07139,107,250,634
归属于母公司股东权益合计73,010,725,504.8671,675,619,971.9770,865,778,972.8369,990,684,153.29
股东权益合计85,300,969,282.5783,742,363,721.0783,157,511,917.6382,228,621,195.06
负债和股东权益合计225,871,891,689.81221,209,430,148.17223,741,345,791.7221,335,871,829.06
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计72,342,373,807.62304,650,625,623.94219,416,492,667.27144,842,680,880.61
经营活动现金流出小计74,546,689,410.83298,823,367,892.61216,633,528,211.01144,327,377,497.58
经营活动产生的现金流量净额-2,204,315,603.215,827,257,731.332,782,964,456.26515,303,383.03
投资活动现金流入小计16,458,582,841.150,433,234,630.1519,354,120,323.7312,895,694,795.5
投资活动现金流出小计17,431,520,246.1150,017,254,930.4618,996,138,579.9410,862,517,080.29
投资活动产生的现金流量净额-972,937,405.01415,979,699.69357,981,743.792,033,177,715.21
筹资活动现金流入小计23,252,698,353.1874,149,022,397.9755,183,838,786.6341,732,726,990.63
筹资活动现金流出小计19,388,489,487.1976,012,952,776.6355,047,062,826.0637,969,626,925.64
筹资活动产生的现金流量净额3,864,208,865.99-1,863,930,378.66136,775,960.573,763,100,064.99
汇率变动对现金及现金等价物的影响4,038,703.532,156,741.31-22,872,683.73-8,187,361.97
现金及现金等价物净增加额690,994,561.34,381,463,793.673,254,849,476.896,303,393,801.26
期末现金及现金等价物余额32,572,267,356.1731,881,272,794.8730,754,658,478.0933,803,202,802.46
最新报告期:2025-05-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投刘若飞,贺菊颖1.351.491.642025-05-06
华福证券何展聪,陈铁林1.291.451.642025-05-06
中金公司张琎,朱言音1.341.45--2025-05-01
平安证券叶寅,倪亦道,王钰畅1.461.661.782025-04-29
东吴证券冉胜男,朱国广1.351.521.712025-04-01
TOP↑